Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Potential effectiveness and safety of olanzapine in refractory panic disorder.

Hollifield M, Thompson PM, Ruiz JE, Uhlenhuth EH.

Depress Anxiety. 2005;21(1):33-40.

PMID:
15786486
2.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
3.

Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.

Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.

Pharmacopsychiatry. 2006 Mar;39(2):60-5.

PMID:
16555166
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
6.

Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.

Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH.

J Clin Psychiatry. 2009 Nov;70(11):1563-70. doi: 10.4088/JCP.08m04485blu. Epub 2009 Oct 6.

7.

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.

Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.

J Psychiatr Res. 2002 Jul-Aug;36(4):229-36.

PMID:
12191627
8.

Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.

Sepede G, De Berardis D, Gambi F, Campanella D, La Rovere R, D'Amico M, Cicconetti A, Penna L, Peca S, Carano A, Mancini E, Salerno RM, Ferro FM.

J Clin Psychopharmacol. 2006 Feb;26(1):45-9.

PMID:
16415705
9.

The efficacy of milnacipran in panic disorder: an open trial.

Blaya C, Seganfredo AC, Dornelles M, Torres M, Paludo A, Heldt E, Manfro GG.

Int Clin Psychopharmacol. 2007 May;22(3):153-8.

PMID:
17414741
10.

Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.

Kasper S, Resinger E.

Eur Neuropsychopharmacol. 2001 Aug;11(4):307-21. Review.

PMID:
11532386
11.

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.

Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD.

Am J Psychiatry. 1998 Nov;155(11):1570-7. Erratum in: Am J Psychiatry 1999 Jan;156(1):161.

PMID:
9812120
12.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group..

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
13.

New developments in panic disorder.

Marzol PC, Pollack MH.

Curr Psychiatry Rep. 2000 Aug;2(4):353-7. Review.

PMID:
11122981
14.

The pharmacotherapy of panic disorder.

Pollack MH.

J Clin Psychiatry. 2005;66 Suppl 4:23-7.

15.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.

J Clin Psychiatry. 2007 Jan;68(1):58-68.

PMID:
17284131
16.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
17.

Panic attacks with psychotic features.

Galynker I, Ieronimo C, Perez-Acquino A, Lee Y, Winston A.

J Clin Psychiatry. 1996 Sep;57(9):402-6.

PMID:
9746448
18.

Olanzapine augmentation in panic disorder: a case report.

Chao I.

Pharmacopsychiatry. 2004 Sep;37(5):239-40.

PMID:
15470803
19.
20.

Panic disorder: treatment with valproate.

Woodman CL, Noyes R Jr.

J Clin Psychiatry. 1994 Apr;55(4):134-6.

PMID:
8071256

Supplemental Content

Support Center